参考文献/References:
[1] CHEN Nanshan, ZHOU Min, DONG Xuan, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet (London, England), 2020, 395(1223): 507-513.
[2] Seven days in medicine:8-14 Jan 2020 [EB/OL]. BMJ,2020:368. DOI: https://doi.org/10.1136/bmj.b132.
[3] 周玉平, 朱传新, 龚娇芳, 等.新型肺炎患者临床实验室检测结果分析[J].现代检验医学杂志, 2020, 35(2): 83-87. ZHOU Yuping, ZHU Chuanxin, GONG Jiaofang, et al. Analysis of clinical laboratory test results in patients with novel coronavirus pneumonia [J]. Journal of Modern Laboratory Medicine, 2020,35(2): 83-87.
[4] 中华人民共和国国家卫生健康委员会（国卫办医函〔2020〕184号）.关于印发新型冠状病毒感染的肺炎诊疗方案（试行第七版）的通知 [EB/OL].(2020-03-04). http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml. National Health Commission of the People’s Republic of China .Medical Letter of the State Health Office
[2020] No. 184.Notification on the issuance of COVID-19 medical program (trial seventh edition) [EB/OL].(2020-03-04). http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
[5] WOODSIDE D G, LIU S, GINSBERG M H. Integrin activation[J].Thrombosis Haemostasis, 2001, 86(1): 316-323.
[6] ZHANG L, LONG Y, XIAO H, et al. Use of D-dimer in oral anticoagulation therapy[J]. International Journal of Laboratory Hematology, 2018, 42(5): 503-507.
[7] TANAKA T, NARAZAKI M, KISHIMOTO T. Immunotherapeutic implications of IL-6 blockade for cytokine storm[J]. Immunotherapy, 2016, 8(8): 959-970.
[8] CHEN Guang , WU Di, GUO Wei, et al. Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019[J]. J Clin Invest, 2020, 130(5):2620-2629
[9] 闫美田，郑雨桐，孙艳美，等.新型冠状病毒肺炎患者血液CRP,CREA,ALB,IL-6水平检测对疾病预后的应用价值分析 [J]．现代检验医学杂志, 2020,35(2): 106-109． YAN Meitian, ZHENG Yutong, SUN Yanmei, et al. Analysis of the value of detection of blood CRP,CREA,ALB and IL-6 level in patients with new coronavirus pneumonia to the prognosis of the disease[J]. Journal of Modern Laboratory Medicine, 2020,35(2): 106-109.
[10] 陈蕾，刘辉国，刘威，等.2019 新型冠状病毒肺炎 29 例临床特征分析[J/OL].中华结核和呼吸杂志, 2020,43(3):203- 208． CHEN Lei, LIU Huiguo, LIU Wei, et al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia [J/OL]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2020,43(3):203- 208.
[11] B.RTSCH P, HAEBERLI A, FRANCIOLLI M, et al. Coagulation and fibrinolysis in acute mountain sickness and beginning pulmonary edema[J]. Journal of Applied Physiology (Bethesda, Md: 1985), 1989, 66(5): 2136-2144.
[12] 刘艳霞, 区静怡, 黄颖, 等.新型冠状病毒肺炎患者外周血淋巴细胞及其亚群检测的临床意义[J].现代检验医学杂志, 2020,35(4): 94-96，105. LIU Yanxia, QU Jingyi, HUANG Ying, et al. Clinical significance of detection of peripheral blood lymphocyte and its subgroups in patients with coronavirus disease 2019[J]. Journal of Modern Laboratory Medicine, 2020,35(4): 94-96, 105.
[13] ISIDORI A M, MINNETTI M, SBARDELLA E, et al. Mechanisms in endocrinology: The spectrum of haemostatic abnormalities in glucocorticoid excess and defect[J]. European Journal of Endocrinology, 2015, 173(3): R101-R113.
[14] JIANG Huiwen, LIU Lin, GUO Tao, et al. Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy [J]. Annals of Hematology, 2019, 98(7): 1721-1732.
[15] LEVI M, VAN DER POLL T, BüLLER H R. Bidirectional relation between inflammation and coagulation[J]. Circulation, 2004, 109(22): 2698-2704.
[16] KATO H. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects[J]. Arteriosclerosis Thrombosis and Vascular Biology, 2002, 22(4): 539-548.
[17] WALLACE A, ALBADAWI H, HOANG P, et al. Statins as a preventative therapy for venous thromboembolism[J]. Cardiovascular Diagnosis and Therapy, 2017, 7(Suppl 3): S207-S218.
[18] REFAAI M, RILEY P, MARDOVINA T, et al. The clinical significance of fibrin monomers[J]. Thrombosis and Haemostasis, 2018, 118(11): 1856-1866.
[19] LIPINSKI B, EGYUD L G. Resistance of cancer cells to immune recognition and killing[J]. Medical Hypotheses, 2000, 54(3): 456-460.
相似文献/References:
[1]汪建军,余艳丽,任超杰.胶乳增强免疫比浊法两种定量试剂检测D-二聚体的评价[J].现代检验医学杂志,2015,30(05):141.[doi:10.3969/j.issn.1671-7414.2015.05.044]
WANG Jian-jun,YU Yan-li,REN Chao-jie.Evaluation of Two Kinds of Quantitative Reagents
for Detection of D-Dimer by Latex Enhanced Immune Turbidity[J].Journal of Modern Laboratory Medicine,2015,30(02):141.[doi:10.3969/j.issn.1671-7414.2015.05.044]
[2]施瑞洁,刘文康,李博,等.血浆D-D，FDP及血清hs-CRP检测对多发性腔隙性脑梗死的临床意义[J].现代检验医学杂志,2015,30(06):75.[doi:10.3969/j.issn.1671-7414.2015.06.021]
SHI Rui-jie,LIU Wen-kang,LI Bo,et al.Clinical Study on Plasma D-D，FDP and Sera hs-CRP
Test for Multipleh Lacunar Infarction[J].Journal of Modern Laboratory Medicine,2015,30(02):75.[doi:10.3969/j.issn.1671-7414.2015.06.021]
[3]刘 莎,江咏梅,张 鸽,等.两种试剂D-二聚体检测值
与纤维蛋白降解产物值的相关性研究[J].现代检验医学杂志,2015,30(01):108.[doi:10.3969/j.issn.1671-7414.2015.01.030]
LIU Sha,JIANG Yong-mei,ZHANG Ge,et al.Study of the Correlation of Testing Results by Two Different
D-dimer Reagents with Fibrin Degradation Products Result Values[J].Journal of Modern Laboratory Medicine,2015,30(02):108.[doi:10.3969/j.issn.1671-7414.2015.01.030]
[4]张红雨,马兴璇.联合检测D-二聚体和CA153在乳腺癌诊治中的临床意义[J].现代检验医学杂志,2015,30(02):137.[doi:10.3969/j.issn.1671-7414.2015.02.043]
[5]宋文炜.血浆D-二聚体检测对甲状腺癌患者的临床意义[J].现代检验医学杂志,2016,31(06):138.[doi:10.3969/j.issn.1671-7414.2016.06.041]
SONG Wen-wei.Clinical Significance of Plasma D-dimer Testing
in Patients with Thyroid Cancer[J].Journal of Modern Laboratory Medicine,2016,31(02):138.[doi:10.3969/j.issn.1671-7414.2016.06.041]
[6]谢 辉,刘玮玮b,郭 娟a,等.新型冠状病毒肺炎疫情下检验医学临床服务管理的探索[J].现代检验医学杂志,2020,35(03):81.[doi:10.3969/j.issn.1671-7414.2020.03.020]
XIE Huia,LIU Wei-weib,GUO Juana,et al.Exploration on Clinical Service Management of Laboratory Medicine
during COVID-19 Epidemic Period[J].Journal of Modern Laboratory Medicine,2020,35(02):81.[doi:10.3969/j.issn.1671-7414.2020.03.020]
[7]朱传新,周玉平,何 艳,等.92 例新冠肺炎病毒感染患者早期外周血白细胞形态分析[J].现代检验医学杂志,2020,35(03):94.[doi:10.3969/j.issn.1671-7414.2020.03.024]
ZHU Chuan-xin,ZHOU Yu-ping,HE Yan,et al.Morphological Analysis of Early Peripheral Blood Leukocytes in 92 Patients
with New Coronary Pneumonia[J].Journal of Modern Laboratory Medicine,2020,35(02):94.[doi:10.3969/j.issn.1671-7414.2020.03.024]
[8]刘艳霞,区静怡,黄 颖,等.新型冠状病毒肺炎患者外周血淋巴细胞及其亚群检测的临床意义[J].现代检验医学杂志,2020,35(04):94.[doi:10.3969/j.issn.1671-7414.2020.04.023]
LIU Yan-xia,OU Jing-yi,HUANG Ying,et al.Clinical Significance of Detection of Peripheral Blood Lymphocyte and Its Subgroups in Patients with Coronavirus Disease 2019[J].Journal of Modern Laboratory Medicine,2020,35(02):94.[doi:10.3969/j.issn.1671-7414.2020.04.023]
[9]佟 丽,黄丽萍,石晓霞,等.血栓弹力图检测新型冠状病毒肺炎患者凝血功能的探讨分析[J].现代检验医学杂志,2020,35(04):97.[doi:10.3969/j.issn.1671-7414.2020.04.024]
TONG Li,HUANG Li-ping,SHI Xiao-xia,et al.Investigation and Analysis of Thromboelastography in the Detection of COVID-19 Patients[J].Journal of Modern Laboratory Medicine,2020,35(02):97.[doi:10.3969/j.issn.1671-7414.2020.04.024]
[10]朱旭阳,叶寒青,陈文亥,等.新型冠状病毒肺炎患者血清SARS-CoV-2 抗体的检测分析[J].现代检验医学杂志,2020,35(04):106.[doi:10.3969/j.issn.1671-7414.2020.04.026]
ZHU Xu-yang,YE Han-qing,CHEN Wen-hai,et al.Preliminary Analysis of Serum Antibodies Against SARS-CoV-2 in Patient with Coronavirus Disease 2019[J].Journal of Modern Laboratory Medicine,2020,35(02):106.[doi:10.3969/j.issn.1671-7414.2020.04.026]